Correlation Between Cingulate Warrants and ESSA Pharma
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and ESSA Pharma, you can compare the effects of market volatilities on Cingulate Warrants and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and ESSA Pharma.
Diversification Opportunities for Cingulate Warrants and ESSA Pharma
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cingulate and ESSA is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and ESSA Pharma go up and down completely randomly.
Pair Corralation between Cingulate Warrants and ESSA Pharma
Assuming the 90 days horizon Cingulate Warrants is expected to generate 19.47 times more return on investment than ESSA Pharma. However, Cingulate Warrants is 19.47 times more volatile than ESSA Pharma. It trades about 0.16 of its potential returns per unit of risk. ESSA Pharma is currently generating about -0.05 per unit of risk. If you would invest 2.00 in Cingulate Warrants on September 5, 2024 and sell it today you would earn a total of 2.85 from holding Cingulate Warrants or generate 142.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 87.9% |
| Values | Daily Returns |
Cingulate Warrants vs. ESSA Pharma
Performance |
| Timeline |
| Cingulate Warrants |
| ESSA Pharma |
Cingulate Warrants and ESSA Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and ESSA Pharma
The main advantage of trading using opposite Cingulate Warrants and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd |
| ESSA Pharma vs. Candel Therapeutics | ESSA Pharma vs. Cingulate Warrants | ESSA Pharma vs. Unicycive Therapeutics | ESSA Pharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |